Home/Pipeline/Allogeneic cell therapeutics development

Allogeneic cell therapeutics development

Not specified

ResearchActive

Key Facts

Indication
Not specified
Phase
Research
Status
Active
Company

About SaxoCell

SaxoCell is a privately held, non-profit consortium founded in 2001 and based in Dresden, Germany. It operates as a regional innovation cluster uniting academic, clinical, and industrial partners to advance the field of cell and gene therapy. Its core mission is to develop more affordable and accessible allogeneic (off-the-shelf) cell therapeutics through research projects focused on novel applications, production methods, and automation. The cluster is pre-revenue, acting as a collaborative R&D and technology transfer engine rather than a single commercial biotech entity.

View full company profile

Other Not specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved